Evidence map›Paper›PMID 35328419›Full record

ReviewInternational journal of molecular sciences2022

Micronutrient Improvement of Epithelial Barrier Function in Various Disease States: A Case for Adjuvant Therapy.

Katherine M DiGuilio, Elizabeth Rybakovsky, Reza Abdavies, Romy Chamoun, Colleen A Flounders, Ariel Shepley-McTaggart, Ronald N Harty, James M Mullin

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. The gut microbiota in malnutrition.Nature reviews. Microbiology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Quercetin improves and protects Calu-3 airway epithelial barrier function.Frontiers in cell and developmental biology · 2023
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Katherine M DiGuilioLankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
Elizabeth RybakovskyLankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
Reza AbdaviesDepartment of Biology, Temple University, 1900 North 12th Street, Philadelphia, PA 19122, USA.
Romy ChamounDepartment of Medicine, Lankenau Medical Center, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.
Colleen A FloundersDepartment of Food and Nutrition Services, Pennsylvania Hospital, 800 Spruce Street, Philadelphia, PA 19107, USA.
Ariel Shepley-McTaggartDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce St., Philadelphia, PA 19104, USA.
Ronald N HartyDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce St., Philadelphia, PA 19104, USA.ORCID 0000-0001-6596-0414
James M MullinLankenau Institute for Medical Research, 100 Lancaster Avenue, Wynnewood, PA 19096, USA.ORCID 0000-0001-5285-7530
Lankenau Institute for Medical Research · USUniversity of Pennsylvania · USLankenau Medical Center · USPennsylvania Hospital · USTemple University · US

Funding

VMD-PhD Training in Infectious Disease-Related ResearchT32AI070077 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Michael Lee Atchison · 2008 to 2026
$3.5M
NIAID NIH HHS T32 AI070077
6 · The paper itself

Abstract

The published literature makes a very strong case that a wide range of disease morbidity associates with and may in part be due to epithelial barrier leak. An equally large body of published literature substantiates that a diverse group of micronutrients can reduce barrier leak across a wide array of epithelial tissue types, stemming from both cell culture as well as animal and human tissue models. Conversely, micronutrient deficiencies can exacerbate both barrier leak and morbidity. Focusing on zinc, Vitamin A and Vitamin D, this review shows that at concentrations above RDA levels but well below toxicity limits, these micronutrients can induce cell- and tissue-specific molecular-level changes in tight junctional complexes (and by other mechanisms) that reduce barrier leak. An opportunity now exists in critical care-but also medical prophylactic and therapeutic care in general-to consider implementation of select micronutrients at elevated dosages as adjuvant therapeutics in a variety of disease management. This consideration is particularly pointed amidst the COVID-19 pandemic.

Indexed as

AnimalsCOVID-19HumansInflammatory Bowel DiseasesIntestinal MucosaMicronutrientsPandemicsSARS-CoV-2Tight JunctionsVitamin AVitamin DVitaminsZincMicronutrientsVitamin AVitamin DVitaminsZincbarrier functionclaudinCOVIDcritical careinflammationmicronutrientsepsistight junctionvirusVitamin AVitamin Dzinc

Identifiers

PMID35328419
PMCPMC8951934
OpenAlexW4220745649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.